Skip to main content
. Author manuscript; available in PMC: 2010 Apr 14.
Published in final edited form as: Thromb Haemost. 2008 Apr;99(4):691–700. doi: 10.1160/TH07-11-0699

Table 1. Baseline characteristics of subjects.

Adapted from (14).

Variables Type 2 diabetic subjects Non-diabetic subjects

Patients (n) 20 18
Sex (male/female)   6/14   07 / 11
Age (years) # 53.0 (49.1; 56.9) 52.9 (49.2; 56.6)
HbA1c (%) 11.7 [9.50; 13.8]a   5.60 [5.30; 5.90] a
Venous glucose (mM) # 14.6 (10.8; 18.4)a   5.18 (4.56; 5.80) a
Fasting Insulin (mU/l) 11.0 [6.70; 15.8] 13.7 [8.9; 28.8]
Insulin resistance (HOMA) #   5.18 (3.99; 6.95)b   3.11 (2.29; 7.42)b
Fibrinogen (g/l) #   4.25 (3.88; 4.63)   4.02 (3.59; 4.45)
Duration of diabetes (years) 11.0 (8.00; 15.0)

Note:

a

P < 0.001;

b

P< 0.05;

#

Data normally distributed and reported as mean (95% confidence interval); Insulin resistance = (fasting insulin × fasting venous glucose)/22.5.